Acute Myeloid Leukemia With Minimal Differentiation C0522631
A subtype of acute myeloid leukemia where the abnormal cells show very little maturity, making them hard to classify under the microscope. It can affect both children and adults and typically requires intensive treatment. Prognosis depends on additional genetic factors.
Key facts at a glance
- ICD-10
- C92.61, C92.A1, C92.62
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- critical
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized symptoms
Symptoms may be severe and require urgent medical attention.
Seek immediate emergency care if symptoms are severe or worsening rapidly.
Vision loss
Fatigue
(hematologic)Fever
(hematologic)Bone pain
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Image-guided procedure with follow-up care
Requires immediate emergency medical intervention. Do not delay treatment.
Induction Chemotherapy
Standard AML induction chemotherapy with cytarabine and anthracycline-based regimen. Hospitalization is required for administration and management of expected myelosuppression and infectious complications.
Differentiation Therapy with ATRA
All-trans retinoic acid may be considered as part of combination therapy to promote differentiation of leukemic blasts. This approach is particularly relevant given the primitive nature of minimally differentiated cells.
Additional treatment options
Stem Cell Transplantation
Allogeneic transplantation is recommended for eligible patients in first remission. This is particularly important for high-risk features or those with persistent minimal residual disease.
procedureConsolidation Chemotherapy
Additional chemotherapy cycles following successful induction to consolidate remission and reduce relapse risk. Typically involves intermediate to high-dose cytarabine-based regimens.
medicationResponse and Toxicity Monitoring
Comprehensive monitoring including complete blood counts, bone marrow assessment, organ function tests, and infection surveillance throughout treatment to optimize outcomes and manage complications.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Call emergency services (911) immediately
Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.
Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.
Frequently asked questions
Common questions about this topic.
What is Acute Myeloid Leukemia With Minimal Differentiation C0522631?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Arber DA, Orazi A, Hasserjian RP, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias. Blood. 2022.
Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Haematologica. 2022.
Dohner H, Estey EH, Amadori S, et al. Diagnosis and Management of Acute Myeloid Leukemia in Adults. N Engl J Med. 2021.
Porwit A, Bene MC. Flow Cytometry in the Diagnosis of Acute Leukemias With Minimal Differentiation. Leuk Lymphoma. 2020.
Medication Comparisons
Compare medications used to treat Acute Myeloid Leukemia With Minimal Differentiation C0522631. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy